Scientific ProgramThursday, November 12, 2026 |
 |
Workshops and Courses:
| 09:00-14:00 | Practical workshop of Intrapartum Ultrasound | Hall D |
| 14:30-17:30 | INDUSTRY SUPPORTED SESSION | Hall B |
| 13:00-14:30 | DO WE TRUST MEDICAL PUBLICATIONS? | HALL A |
| Capsule |
Are Clinical activity and scientific evidence mutually exclusive? |
|
| Chairpersons | ||
| 13:00-13:15 |
FMM: Why we keep using fetal heart rate monitoring -an unproven technology that is associated with high CS rate and its related complications |
|
| 13:15-13:20 | Discussion | |
| 13:20-13:35 |
IVF: Ovulation stimulation – Do we trust scientific evidence? |
|
| 13:35-13:40 | Discussion | |
| 13:40-13:55 |
GYNECOLOGY: Endometriosis: Enucleation of endometriomas can lead to ovarian failure – should we not operate until completion of family planning? |
|
| 13:55-14:00 | Discussion | |
| 14:00-14:15 |
GENETICS: PGT-A, the use of PGT-A is increasing exponentially, despite no RCT’s proving an increase in LBR? |
|
| 14:20-14:30 | General Discussion | |
| 14:30 15:30 | INTEGRITY IN SCIENCE | HALL A |
| Capsule | COGI continues this educational series by examining the escalating “paper mill” crisis in scientific publishing. Notably, fraudulent authors were registered and later proposed as reviewers, and it took two years to uncover the forgery network. The peer-review process is also becoming increasingly challenging. | |
| Chairpersons | ||
| 14:30-14:45 |
Peer review process is deteriorating: Where to go from here – Can AI assist or replace reviewers? |
|
| 14:45-14:50 | Discussion | |
| 14:50-15:05 |
Peer review is in peril: What can we do about it? |
|
| 15:05-15:10 | Discussion | |
| 15:10-15:25 |
How to reduce research waste: What can scientists, universities and funding bodies do about it. |
|
| 15:25-15:30 | Discussion | |
| 15:30-16:00 | Coffee break |
| 16:00-17:00 | OBESITY: RISK DURING DIFFERENT PHASES OF LIFE | HALL A |
| Capsule | Obesity can reduce ovulation, leading to hormonal imbalance, and increased complications and comorbidities affecting fertility, pregnancy and menopause. Now that we have effective treatment why not use it for all? | |
| Chairpersons | ||
| 16:00-16:15 |
Reproductive years: Does age affect the success of treatment? What is the solution? |
|
| 16:15-16:20 | Discussion | |
| 16:20-16:35 |
Should we counsel patients to lose weight before pregnancy? What are the risks of obesity during pregnancy and labor |
|
| 16:35-16:40 | Discussion | |
| 16:40-16:55 |
GLP1-antagonist is it risk-free? What else is in the pipeline? |
|
| 16:55-17:00 | Discussion | |
| 17:00-18:30 | WHAT IS NEW IN OUR FIELD? | HALL A |
| Capsule |
In vitro gene editing was performed successful, but also illegally, Techniques that can cure a baby or embryos from lethal disease are probably welcome but the road to abuse remains widely open. |
|
| Chairpersons | ||
| 17:00-17:15 |
Single Gene correction PGT-M is compelling – what has been achieved and at what cost? |
|
| 17:15-17:20 | Discussion | |
| 17:20-17:40 |
Slowing the ovarian clock: mTOR inhibition and the future of menopause |
|
| 17:40-17:45 | Discussion | |
| 17:45-18:05 |
Melatonin: Using this potent antioxidant to improve aspects of reproduction and pregnancy/back to the future. |
|
| 18:05-18:10 | Discussion | |
| 18:10-18:25 |
Finding the unfindable: AI-based rare sperm recovery and the redefinition of Azoospermia |
|
| 18:25-18:30 | Discussion | |
| 18:30-19:30 | OPENING SESSION | HALL A |
| Chairpersons | ||
| 18:30-18:35 | Welcome to Athens | |
| 18:35-19:20 |
Keynote lecture in honor of Nobel Prize Laureate Robert G. Edwards |
|
| 19:20-19:30 | Young Scientist Best Abstract Award | |
| 19:30-20:30 | Networking Reception |
